ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Isocyanate-Modified Melatplatin(IV) Enhances Antitumor Efficacy via TCF4/COL6A3-Mediated Extracellular Matrix Remodeling and cGAS-STING Pathway Activation in Bladder Cancer.
Linhui Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.